Lever
Lifestyle
- adequate hydration
- regular physical activity
- stress management
Blutwerte · Marker
MCHC
Mean Corpuscular Hemoglobin Concentration
Blutbild
- Einheit:
- g/dL
MCHC quantifies the average concentration of hemoglobin in a given volume of packed red blood cells.
Reference Ranges
Reference
32–36g/dL
32
36
LowNormalHigh
Reference
Unit · g/dLReference ranges may vary slightly based on laboratory standards and population demographics.
Overview
Übersicht
Mean Corpuscular Hemoglobin Concentration (MCHC) is a measure of the average concentration of hemoglobin in a given volume of packed red blood cells. It is calculated by dividing the hemoglobin concentration by the hematocrit and is expressed in grams per deciliter (g/dL). MCHC provides insight into the hemoglobin content relative to the size of red blood cells, offering a perspective on the cell's hemoglobin saturation. Clinically, MCHC is an important parameter in the complete blood count (CBC) and is used to evaluate and diagnose various types of anemia. Elevated MCHC values are often associated with hereditary spherocytosis, a condition characterized by the presence of spherically shaped red blood cells, while low MCHC values can indicate hypochromic anemia, where red blood cells have reduced hemoglobin content. For athletes and biohackers, MCHC may be relevant as it reflects the efficiency of oxygen transport in the blood, which can impact endurance and performance. However, MCHC is less commonly targeted for optimization compared to other hematological parameters like hemoglobin or hematocrit. It is important to consider factors such as recent blood loss, hydration status, and laboratory variability when interpreting MCHC values. Fasting is not required for MCHC testing, and it is not significantly affected by the time of day. However, conditions such as dehydration or recent physical exertion can influence results, necessitating careful consideration of these factors during interpretation.
Klinische Bedeutung
Elevated MCHC values can indicate hereditary spherocytosis or other forms of spherocytosis, while reduced values suggest hypochromic anemia. It provides insight into the hemoglobin saturation of red blood cells.
Dynamics
Trend Interpretation
Rising Values
Progressively rising MCHC values may suggest worsening spherocytosis or other hemolytic conditions. Re-test in 4 weeks if values continue to rise.
Falling Values
Progressively falling MCHC values could indicate increasing severity of hypochromic anemia or iron deficiency.
Re-test Interval
4 weeks if outside optimal range
Etiology
Causes — High & Low
Cause
Elevated Levels
- hereditary spherocytosis
- autoimmune hemolytic anemia
- severe burns
- hyperlipidemia
- cold agglutinin disease
Cause
Low Levels
- iron deficiency anemia
- thalassemia
- chronic blood loss
- chronic disease anemia
- lead poisoning
Protocol
How to Optimize
Lever
Nutrition
- iron-rich foods
- vitamin B12 sources
- folate-rich foods
Lever
Supplementation
- iron supplements
- vitamin B12 supplements
- folic acid
Note:
Consult a healthcare provider before starting supplements, especially iron, due to potential side effects and contraindications.
Testing Guidelines
✓Fasting Not Required
✓Not Time-Sensitive
Draw blood at the same time of day for consistency due to diurnal variations.
Testing Frequency
Annually for routine health checks, more frequently if monitoring anemia or other hematological conditions.
Interfering Factors
- Recent intense exercise
- Dehydration
- Recent blood transfusion
Open Research Questions
Current research suggests that reference ranges for MCHC in diverse populations, including transgender individuals and specific age groups, remain inadequately defined, leading to potential misinterpretation of results. Researchers have not yet established optimal MCHC targets for various hematological conditions, particularly in pediatric and newborn populations. Additionally, clinical questions about the impact of factors such as altitude and delivery methods on MCHC levels in newborns remain unanswered.
46 Research Publications
534
Total Citations
32
Human/RCT
1.6
Avg. Influence
2025
Latest
Sort
Filter
01Top
#01
Fetal hemoglobin, sickling, and sickle cell disease.
ReviewInfluence3.0
60
This study explored the role of fetal hemoglobin in sickle cell disease, noting that variations in mean corpuscular hemoglobin concentration (MCHC) and fetal hemoglobin levels can influence clinical outcomes. Researchers emphasized the need for further studies to clarify these relationships.
02Top
#02
Hematology reference intervals for transgender adults on stable hormone therapy.
HumanInfluence1.0
54
This study established hematologic reference intervals for transgender adults undergoing stable hormone therapy. Researchers observed that hematology parameters for individuals on testosterone or estrogen were similar to those of cisgender males and females, suggesting that existing reference ranges can be used for interpretation.
03Top
#03
Sickle cell disease pathophysiology.
HumanInfluence1.0
47
This study explored the pathophysiology of sickle cell disease, focusing on the role of mean corpuscular hemoglobin concentration (MCHC) in sickle hemoglobin polymerization. Researchers observed that variations in MCHC contribute to differences in anemia severity among sickle syndromes.
04
#04
Increased mean corpuscular haemoglobin concentration: artefact or pathological condition?
HumanInfluence2.0
39
This study focused on the analytical challenges of increased mean corpuscular hemoglobin concentration (MCHC) in laboratory settings. Researchers observed that new parameters could help differentiate between spurious results and true pathological conditions, improving diagnostic accuracy.
05
#05
Cancer risk of petrochemical workers exposed to airborne PAHs in industrial Lanzhou City, China.
HumanInfluence2.0
33
06
#06
A simple laboratory alternative to irreversibly sickled cell (ISC) counts.
Unknown
32
Researchers developed a new method for quantifying irreversibly sickled cells (ISC) in sickle cell disease using cell density measurements. The study found a strong correlation between high-density cells and morphologically identified ISC, suggesting this method could provide a more objective alternative to traditional microscopic counting.
07
#07
Haematological and immunological reference intervals for adult population in the state of Amhara, Ethiopia.
HumanInfluence5.0
24
This study aimed to establish hematological and immunological reference intervals for adults in Amhara, Ethiopia. Researchers found significant differences in parameters like MCHC and RBC counts between genders, highlighting the importance of locally derived reference intervals for clinical interpretation.
08
#08
Handling of lipemic samples in the clinical laboratory.
Review
24
Researchers discussed the impact of lipemia on clinical laboratory results, noting that mean corpuscular hemoglobin concentration (MCHC) can be affected by lipemic samples. They emphasized the need for standardized protocols to manage lipemic samples in laboratories.
09
10
#10
CALIPER Hematology Reference Standards (II).
Higgins Victoria, et al. · American journal of clinical pathology · 2020
HumanInfluence1.0
20
Researchers aimed to create age- and sex-specific hematologic reference intervals for children and adolescents. They found significant variations in hematologic parameters during growth, indicating the necessity for pediatric-specific reference standards for accurate test result interpretation.
Key findings
- 01Researchers observed significant changes in blood parameters as children grow and develop.
- 02All but four of the 27 blood measurements required adjustments based on age, and eight needed adjustments based on sex.
- 03The study created a comprehensive database to improve the interpretation of blood test results in pediatric populations.
Clinical Trials (1)
1
Total Trials
200
Total Enrolled
RDW:MCHC as a Pragmatic Adjunct to SOFA Score in ICU Mortality Assessment
NCT07775911COMPLETED
Sponsor
Sohag University
Enrollment
200
Started
2026
Primary outcome
1. ICU Mortality
Critical Illness
Publication Trend
Research publications about MCHC over time
8totalTrack your bloodwork in PepStack
Log lab results, track trends and optimize your biomarkers over time.
Legal Disclaimer
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer